Impairment of GH/IGF-1 Axis in the Liver of Patients with HCV-Related Chronic Hepatitis. 2018

Simone Carotti, and Michele Pier Luca Guarino, and Francesco Valentini, and Silvio Porzio, and Umberto Vespasiani-Gentilucci, and Giuseppe Perrone, and Maria Zingariello, and Paolo Gallo, and Michele Cicala, and Antonio Picardi, and Sergio Morini
Unit of Microscopic and Ultrastructural Anatomy, University Campus Bio-Medico, Rome, Italy.

Resistance to the action of growth hormone (GH) frequently complicates liver cirrhosis, while, physiologically, the activation of GH receptor (GHR) determines phosphorylation of signal transducer and activator of transcription (STAT)-5 and the consequent induction of insulin-like growth factor-1 (IGF-1) expression. The suppressor of cytokine signaling (SOCS)-3 negatively regulates this intracellular cascade. We aimed to evaluate the hepatic expression of the GH/IGF-1 axis components in the liver of patients with HCV-related chronic hepatitis at different fibrosis stages. The expression of GH/IGF-1 axis components, such as GHR, IGF-1, STAT5-p, and SOCS-3, was assessed by immunohistochemistry at the lobular level in 61 patients with HCV-related hepatitis. At the hepatocyte level, IGF-1 and nuclear STAT5-p positivity scores showed negative correlations with fibrosis stage, while SOCS-3 score a positive one (p<0.05 for all). Furthermore, the reduction of hepatocyte score of IGF-1 expression was associated with the serological parameters of liver damage (p<0.05) and with the increase of the score of IGF-1 expression by hepatic stellate cells (p<0.05). IGF-1 expression by hepatocytes was reduced with fibrosis progression, probably due to the impairment of GHR intracellular cascade by the SOCS-3 activation already in pre-cirrhotic stages. The inverse correlation between IGF-1 expressed by hepatocytes and by hepatic stellate cells suggests that IGF-1 may exert specific functions in different hepatic cells.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D011986 Receptors, Somatotropin Cell surface proteins that bind GROWTH HORMONE with high affinity and trigger intracellular changes influencing the behavior of cells. Activation of growth hormone receptors regulates amino acid transport through cell membranes, RNA translation to protein, DNA transcription, and protein and amino acid catabolism in many cell types. Many of these effects are mediated indirectly through stimulation of the release of somatomedins. Growth Hormone Receptors,Receptors, Growth Hormone,Somatomammotropin Receptors,Somatotropin Receptors,Growth Hormone Receptor,Receptor, Growth Hormone,Receptors, Somatomammotropin,Somatomammotropin Receptor,Somatotropin Receptor,Hormone Receptor, Growth,Hormone Receptors, Growth
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071223 Suppressor of Cytokine Signaling 3 Protein A suppressor of cytokine signaling protein that consists of an N-terminal kinase-inhibitory region, a central SH2 DOMAIN, a characteristic C-terminal SOCS box (a 40-amino acid motif, which functions to recruit E3 UBIQUITIN-PROTEIN LIGASE COMPLEXES). SOCS3 inhibits cytokine signaling by binding to RECEPTOR PROTEIN-TYROSINE KINASES as well as CYTOKINE RECEPTOR GP130; ERYTHROPOIETIN RECEPTORS; INSULIN RECEPTOR; and the LEPTIN RECEPTOR. Its functions include suppression of ERYTHROPOIESIS in the fetal liver. SOCS3 Protein,Suppressor of Cytokine Signaling Protein 3,Protein, SOCS3
D013006 Growth Hormone A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized. Growth Hormone, Recombinant,Pituitary Growth Hormone,Recombinant Growth Hormone,Somatotropin,Somatotropin, Recombinant,Growth Hormone, Pituitary,Growth Hormones Pituitary, Recombinant,Pituitary Growth Hormones, Recombinant,Recombinant Growth Hormones,Recombinant Pituitary Growth Hormones,Recombinant Somatotropins,Somatotropins, Recombinant,Growth Hormones, Recombinant,Recombinant Somatotropin
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus
D050799 STAT5 Transcription Factor A signal transducer and activator of transcription that mediates cellular responses to a variety of CYTOKINES. Stat5 activation is associated with transcription of CELL CYCLE regulators such as CYCLIN KINASE INHIBITOR P21 and anti-apoptotic genes such as BCL-2 GENES. Stat5 is constitutively activated in many patients with acute MYELOID LEUKEMIA. Mammary Gland Factor,Mammary Gland-Specific Nuclear Factor,STAT5 Protein,STAT5a Protein,STAT5a Transcription Factor,STAT5alpha Protein,STAT5b Protein,STAT5b Transcription Factor,STAT5beta Protein,Signal Transducer and Activator of Transcription 5,Signal Transducer and Activator of Transcription 5A,Signal Transducer and Activator of Transcription 5B,Factor, STAT5 Transcription,Mammary Gland Specific Nuclear Factor,Transcription Factor, STAT5,Transcription Factor, STAT5a,Transcription Factor, STAT5b

Related Publications

Simone Carotti, and Michele Pier Luca Guarino, and Francesco Valentini, and Silvio Porzio, and Umberto Vespasiani-Gentilucci, and Giuseppe Perrone, and Maria Zingariello, and Paolo Gallo, and Michele Cicala, and Antonio Picardi, and Sergio Morini
March 2013, Endocrine, metabolic & immune disorders drug targets,
Simone Carotti, and Michele Pier Luca Guarino, and Francesco Valentini, and Silvio Porzio, and Umberto Vespasiani-Gentilucci, and Giuseppe Perrone, and Maria Zingariello, and Paolo Gallo, and Michele Cicala, and Antonio Picardi, and Sergio Morini
June 2008, Clinical endocrinology,
Simone Carotti, and Michele Pier Luca Guarino, and Francesco Valentini, and Silvio Porzio, and Umberto Vespasiani-Gentilucci, and Giuseppe Perrone, and Maria Zingariello, and Paolo Gallo, and Michele Cicala, and Antonio Picardi, and Sergio Morini
July 2003, Journal of viral hepatitis,
Simone Carotti, and Michele Pier Luca Guarino, and Francesco Valentini, and Silvio Porzio, and Umberto Vespasiani-Gentilucci, and Giuseppe Perrone, and Maria Zingariello, and Paolo Gallo, and Michele Cicala, and Antonio Picardi, and Sergio Morini
November 2019, Journal of endocrinological investigation,
Simone Carotti, and Michele Pier Luca Guarino, and Francesco Valentini, and Silvio Porzio, and Umberto Vespasiani-Gentilucci, and Giuseppe Perrone, and Maria Zingariello, and Paolo Gallo, and Michele Cicala, and Antonio Picardi, and Sergio Morini
January 2021, Frontiers in molecular neuroscience,
Simone Carotti, and Michele Pier Luca Guarino, and Francesco Valentini, and Silvio Porzio, and Umberto Vespasiani-Gentilucci, and Giuseppe Perrone, and Maria Zingariello, and Paolo Gallo, and Michele Cicala, and Antonio Picardi, and Sergio Morini
December 2019, Clinical medicine & research,
Simone Carotti, and Michele Pier Luca Guarino, and Francesco Valentini, and Silvio Porzio, and Umberto Vespasiani-Gentilucci, and Giuseppe Perrone, and Maria Zingariello, and Paolo Gallo, and Michele Cicala, and Antonio Picardi, and Sergio Morini
February 2002, Journal of endocrinological investigation,
Simone Carotti, and Michele Pier Luca Guarino, and Francesco Valentini, and Silvio Porzio, and Umberto Vespasiani-Gentilucci, and Giuseppe Perrone, and Maria Zingariello, and Paolo Gallo, and Michele Cicala, and Antonio Picardi, and Sergio Morini
August 2009, Current cardiology reviews,
Simone Carotti, and Michele Pier Luca Guarino, and Francesco Valentini, and Silvio Porzio, and Umberto Vespasiani-Gentilucci, and Giuseppe Perrone, and Maria Zingariello, and Paolo Gallo, and Michele Cicala, and Antonio Picardi, and Sergio Morini
October 2016, Human molecular genetics,
Simone Carotti, and Michele Pier Luca Guarino, and Francesco Valentini, and Silvio Porzio, and Umberto Vespasiani-Gentilucci, and Giuseppe Perrone, and Maria Zingariello, and Paolo Gallo, and Michele Cicala, and Antonio Picardi, and Sergio Morini
June 2013, Nature reviews. Endocrinology,
Copied contents to your clipboard!